Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Strength Training With Restricted Blood Flow in Adults With Obesity

Tests strength training with limited blood flow over 8 weeks in adults with obesity.

Plain-language title generated from the registry record
Registry title: Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemical Biomarkers, and Perceived Exertion in Adults With Obesity

Key facts

Where
Tlajomulco de Zúñiga, MexicoSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 30 years old?

Source: NCT07444736, who can take part

Where in Mexico

  • Centro Universitario de TlajomulcoTlajomulco de Zúñiga, MexicoNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centro Universitario de Tlajomulco, Universidad de Guadalajara
Trial code
NCT07444736
Record updated
3 March 2026
Original description
To analyze the effect of 8 weeks of resistance training with blood flow restriction on muscle strength, clinical parameters, biochemical biomarkers, and perceived exertion in adults with obesity.Read full original descriptionShow less

Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemical Biomarkers, and Perceived Exertion in Adults With Obesity

To analyze the effect of 8 weeks of resistance training with blood flow restriction on muscle strength, clinical parameters, biochemical biomarkers, and perceived exertion in adults with obesity.

Inclusion: Adults aged 18 to 40; Both genders; BMI ≥ 30 kg/m\^2 and < 40 kg/m\^2; Signed informed consent form.

Exclusion: Use of beta-blockers or hypoglycemic agents within 7 days prior to the intervention; Personal and family history of vascular disease or deep vein thrombosis; Clinical diagnosis of type 1 diabetes mellitus; Clinical diagnosis of type 2 diabetes mellitus; Clinical diagnosis of hypertension; Clinical diagnosis of acute myocardial infarction or angina pectoris; Postural and biomechanical disorders (knee, foot, and spine); Use of nitrates and calcium channel blockers within 4 days prior to the start of the study; Participants who smoke; Clinical diagnosis of hypothyroidism; Clinical diagnosis of grade 3 obesity; Use of anticoagulants; Pregnant women; Breastfeeding women; Men consuming more than 40 g of alcohol per day or women consuming more than 20 g per day.

ClinicalTrials.gov NCT07444736